EC-Naprosyn is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Canton Laboratories. The primary component is Naproxen.
Product ID | 69437-416_0aa005eb-b5a2-4f9b-9fa8-0c543a7752b3 |
NDC | 69437-416 |
Product Type | Human Prescription Drug |
Proprietary Name | EC-Naprosyn |
Generic Name | Naproxen |
Dosage Form | Tablet, Delayed Release |
Route of Administration | ORAL |
Marketing Start Date | 2016-06-01 |
Marketing Category | NDA / NDA |
Application Number | NDA020067 |
Labeler Name | Canton Laboratories |
Substance Name | NAPROXEN |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2016-06-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020067 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2016-06-01 |
Ingredient | Strength |
---|---|
NAPROXEN | 500 mg/1 |
SPL SET ID: | 8bff5df5-d856-4237-b6a8-ae445b454844 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
UPC Code | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0004-6415 | EC-Naprosyn | naproxen |
69437-415 | EC-Naprosyn | EC-Naprosyn |
69437-416 | EC-Naprosyn | EC-Naprosyn |
0363-9609 | BACK AND MUSCLE PAIN | NAPROXEN |
0121-0899 | Naprosyn | Naproxen |
0121-1798 | Naprosyn | Naproxen |
0121-2697 | Naprosyn | Naproxen |
0054-3630 | Naproxen | Naproxen |
0093-1005 | Naproxen | Naproxen |
0093-1006 | Naproxen | Naproxen |
0143-1346 | Naproxen | Naproxen |
0143-1347 | Naproxen | Naproxen |
0143-1348 | Naproxen | Naproxen |
0179-1978 | Naproxen | Naproxen |
0440-1852 | Naproxen | Naproxen |
0440-7852 | Naproxen | Naproxen |
0615-1504 | Naproxen | Naproxen |
0615-3562 | Naproxen | Naproxen |
0615-3563 | Naproxen | Naproxen |
0615-7709 | Naproxen | Naproxen |
0615-7892 | Naproxen | Naproxen |
0615-8094 | Naproxen | Naproxen |
10544-010 | Naproxen | Naproxen |
10544-016 | Naproxen | Naproxen |
10544-019 | Naproxen | Naproxen |
10544-044 | Naproxen | Naproxen |
10544-061 | Naproxen | Naproxen |
10544-111 | NAPROXEN | NAPROXEN |
10544-277 | Naproxen | Naproxen |
10544-278 | Naproxen | Naproxen |
10544-920 | Naproxen | Naproxen |
10544-922 | Naproxen | Naproxen |
10544-939 | Naproxen | Naproxen |
12634-498 | Naproxen | Naproxen |
12634-684 | Naproxen | Naproxen |
21695-084 | Naproxen | Naproxen |
21695-085 | Naproxen | Naproxen |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EC-NAPROSYN 74405354 1920671 Dead/Cancelled |
SYNTEX PUERTO RICO, INC. 1993-06-18 |
EC-NAPROSYN 74401683 1920670 Live/Registered |
ATNAHS PHARMA US LIMITED 1993-06-14 |